(XEMD) Bondbloxx Trust - JP Morgan - Ratings and Ratios
Bonds, USD, Emerging, Short
Dividends
| Dividend Yield | 5.98% |
| Yield on Cost 5y | 8.27% |
| Yield CAGR 5y | 47.02% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 4.54% |
| Value at Risk 5%th | 7.46% |
| Relative Tail Risk | -0.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.30 |
| Alpha | 5.87 |
| CAGR/Max DD | 2.49 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.438 |
| Beta | 0.183 |
| Beta Downside | 0.173 |
| Drawdowns 3y | |
|---|---|
| Max DD | 4.31% |
| Mean DD | 0.90% |
| Median DD | 0.50% |
Description: XEMD Bondbloxx Trust - JP Morgan October 25, 2025
The Bondbloxx ETF Trust – JP Morgan USD Emerging Markets 1-10 Years Bond ETF (ticker XEMD) is a U.S.–based ETF that must allocate at least 80 % of its net assets to USD-denominated emerging-market bonds with maturities between one and ten years, either directly or via derivatives. The fund is classified as non-diversified, meaning it may hold a relatively concentrated set of issuers.
As of the most recent quarterly report, XEMD’s weighted-average yield is roughly 6.8 % and its duration sits near 5.2 years, indicating moderate interest-rate sensitivity. About 70 % of its holdings are sovereign bonds, with the remainder split between quasi-sovereign and corporate issuers, exposing the ETF to fiscal and credit developments in key emerging economies such as Brazil, Indonesia, and South Africa. Consequently, the fund’s performance is strongly linked to two macro drivers: (1) the strength of the U.S. dollar, which affects the relative cost of servicing dollar-denominated debt, and (2) global commodity price trends, which influence fiscal balances and growth prospects in commodity-exporting emerging markets.
If you want a deeper, data-driven dive into XEMD’s risk-adjusted returns and how its exposure aligns with current macro conditions, ValueRay offers a free analytical dashboard that can help you validate the assumptions behind this ETF.
What is the price of XEMD shares?
Over the past week, the price has changed by +0.37%, over one month by +1.04%, over three months by +2.88% and over the past year by +12.30%.
Is XEMD a buy, sell or hold?
What are the forecasts/targets for the XEMD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 52.2 | 17% |
XEMD Fundamental Data Overview December 16, 2025
Beta = 0.58
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 733.6m USD (733.6m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 733.6m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 733.6m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.69% (E(733.6m)/V(733.6m) * Re(6.69%) + (debt-free company))
Discount Rate = 6.69% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for XEMD ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle